03.25.24 -- End-To-End Services And Solutions For Your RNA Manufacturing

Bring your mRNA therapeutics development to commercialization with confidence. Review the mRNA therapeutics journey step-by-step and discover how to meet the critical process, scale, quality, and regulatory needs from development to commercialization.

Break down the steps in a GMP sgRNA project and explore the best ways to transition from early-phase research to process development, and then into the clinic with these continuum sgRNA available in different grades.

Discover the nanoparticle engineering, formulation, and GMP manufacturing solutions that can help you through complex challenges, drive your market success forward, and unlock the power of “small."

Whether you are planning a multipurpose or single-product facility, synthesis speed is key to your production outcome. OligoProcess covers a range of 10 to 1800 mmol and is suitable for quantities required in clinical phases and commercial production.

Choosing the right partner for your analytical and biosafety testing is critical in the race to approval. Learn about our best-in-class, risk-mitigating solutions with technical and regulatory expertise to help you bring life-changing drugs to market.

Our cell therapy product characterization services combine rapid PCR, ELISA, and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research-grade testing available.

Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.

These single-use mixing systems combine high-performance mixing technology with design features that make them easy to use. Efficiently mix the most challenging buffers, media, and biopharmaceutical ingredients.